H.C. Wainwright & Co., LLC’s Post

President and Founder of MERC, Wade Byerly, is back with No. 22 in his Capital Strategy series. Learn more about outgoing #medicalequipment in this post and the pro's and con's of several types of liquidation methods. #healthcareconsulting #capitalplanning

A team of lawyers from Sidley Austin LLP is guiding medical services company CareMax Inc. as it plans to sell its assets during its Chapter 11 case in Delaware. https://lnkd.in/eUKrH43h

💗 Carmat secures equity financing from Vester Finance SA for artificial heart The French medical technology firm designs, manufactures, and markets the Aeson artificial heart. The agreement with Vester Finance SA allows for the issuance of a maximum of 3.5 million shares over 24 months. Under the deal, Vester Finance will subscribe to CARMAT’s ordinary shares at a maximum of 9.96% of the latter’s current share capital, at its discretion and subject to standard contractual conditions. Read more online: https://lnkd.in/eHppBfmv 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Nymbl Systems, a Columbus, OH-based provider of cloud-based practice management software for Orthotics and Prosthetics (O&P), Complex Rehabilitation Technology (CRT), and Home Medical Equipment (HME) providers, received an undisclosed equity investment from Frontier Growth. https://lnkd.in/gjV4U8si

Cork-based medical devices firm PMD Solutions has filed for bankruptcy, citing liquidity issues stemming from delayed payments from a major Irish public sector body. Despite significant efforts to secure short-term financing, the company was unable to continue operations, leading to coordinated bankruptcy filings in both Sweden and Ireland. Read more about how public sector delays and tax authority decisions triggered the company’s downfall here - https://lnkd.in/e4hRfPXV

"Schwazze posts $16 million loss for first quarter Colorado-based Medicine Man Technologies, which does business as Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ), posted a $16 million net loss for the first three months of 2024, deepening its financial hole since last year’s $34.5 million loss. Revenues were down slightly sequentially to $41.6 million from $43.3 million, but up slightly year-over-year from $40 million. But the net loss – a huge swing from the $1.7 million in net income a year ago – must really sting. The company attributed the stale revenue growth to 'pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.' Perhaps a telling sign of internal turbulence at the financially troubled firm, former CEO Nirup Krishnamurthy abruptly resigned in February 'due to personal reasons,' according to a press release from Schwazze. He was replaced by interim CEO Forrest Hoffmaster, who had previously been the company’s chief financial officer." by John Schroyer Green Market Report https://lnkd.in/gKg8yrwx

Paragon 28’s industry leading foot and ankle solutions portfolio is highly complementary to Zimmer Biomet's lower extremities business while creating cross selling opportunities and amplifying Zimmer Biomet's leadership position in Ambulatory Surgical Centers (ASCs). The strategic transaction will further solidify Zimmer Biomet's leadership position across musculoskeletal health and specifically lower extremities.

The #FederalCircuit yesterday issued an important #patent ruling in Vascular Solutions LLC v. Medtronic, Inc. (Sep 16, 2024) that provides valuable guidance on functional claim language. Here are some key takeaways: 1. Independent claims can vary in how they claim disclosed subject matter. The court emphasized that "claiming is not restricted" to require total consistency across independent claims. 2. Functional claim language is permissible. The CAFC clarified that terms like "substantially rigid portion" can be construed functionally, without specifying exact boundaries. 3. Consider expert input carefully. While the district court relied heavily on an expert's skepticism, the CAFC found this led to erroneous conclusions. 4. Remember IPR estoppel. The PTAB's findings on prior art and written description carried weight, even back in district court. These points underscore the importance of thorough, claim-by-claim analysis in patent drafting and litigation. #PatentLaw #FederalCircuit #ClaimConstruction https://lnkd.in/ednAKHfH

Prospect files for bankruptcy: Los Angeles-based Prospect Medical Holdings has filed for Chapter 11 protection as it works to sell 10 of its 16 hospitals. http://dlvr.it/THKpsd

𝐓𝐡𝐞 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐕𝐢𝐬𝐢𝐨𝐧 𝐂𝐚𝐫𝐞 𝐏𝐥𝐚𝐧𝐬 𝐨𝐧 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 In today's optometry market, vision care plans play a crucial role. With rising overhead costs and decreasing reimbursement rates, it’s essential to strategically select lenses to maintain financial health. Here are some key points: - Many ODs overlook lens selection, delegating it to staff, which may not always align with optimal patient care and profitability. - For managed vision care orders, choose lenses and coatings that offer the highest rebate dollars from the plan’s formulary. - For non-managed orders, opt for private-label lenses that match the quality of name-brand options but are more cost-effective. At Partners in Profit, we’ve tailored negotiations with an exclusive lens provider to help our members achieve impressive results, like the “Magic 20” – 𝗮 𝗖𝗢𝗚𝗦 𝗼𝗳 𝗷𝘂𝘀𝘁 𝟮𝟬%. Balance quality patient care and profitability with our strategic approach. Schedule a consultation for personalized advice today!